Every year, millions of older adults take more medications than they need. Some of these drugs were prescribed years ago for a condition that’s now resolved. Others were added to treat side effects from earlier drugs. The result? A daily pill burden that’s not just inconvenient-it’s dangerous. For many, the real health risk isn’t the illness they’re treating, but the medicines meant to treat it.

Why Deprescribing Isn’t Just Stopping Pills

Deprescribing isn’t about randomly cutting drugs. It’s a careful, step-by-step process of reviewing every medication to ask: Is this still helping, or is it hurting? The goal isn’t to stop everything-it’s to stop what’s no longer necessary, harmful, or mismatched with the patient’s current health goals.

This approach became a formal clinical practice around 2012, led by researchers in Canada. Since then, evidence has piled up: reducing unnecessary meds cuts hospital stays, lowers fall risk, and improves quality of life. A 2023 study in JAMA Internal Medicine tracked 372 older adults (average age 76) who underwent structured deprescribing. Despite cutting an average of 1.8 medications per person, their rate of adverse events didn’t rise. In fact, many felt better-less dizziness, fewer stomach issues, more energy.

The Five Medication Classes That Need the Most Attention

Not all drugs are equally risky. Experts have focused on five classes where deprescribing makes the biggest difference:

• Proton-pump inhibitors (PPIs) - Often prescribed long-term for heartburn, but studies show most people don’t need them after 4-8 weeks. Long-term use raises the risk of bone fractures, kidney damage, and infections like C. diff.
• Benzodiazepines and sleep aids - Used for anxiety or insomnia, but these drugs increase fall risk by 40% in older adults. They also blur thinking and worsen memory.
• Antipsychotics - Sometimes prescribed for behavioral symptoms in dementia, even though they’re not approved for that use. They can cause stiffness, tremors, and even sudden death.
• Antihyperglycemics - Blood sugar drugs like sulfonylureas can cause dangerous low blood sugar in older patients, especially if they eat irregularly or have kidney problems.
• Opioid painkillers - Often continued long after surgery or injury heals. They cause constipation, confusion, and addiction risk-even in older adults.

Each of these has a clear, evidence-based deprescribing protocol. For example, the PPI guideline says: check if the original reason still exists, then slowly reduce the dose over 4-8 weeks while watching for rebound symptoms. No sudden stops. No guesswork.

How It Works: The Shed-MEDS Framework

One of the most tested methods is called Shed-MEDS. It stands for:

1. Best Possible Medication History - Get a full list of everything the patient takes, including over-the-counter pills, supplements, and herbal remedies. Many patients forget these.
2. Evaluate - Use tools like STOPP/START criteria to flag drugs that are inappropriate or missing. STOPP tells you what to avoid. START tells you what to add if needed.
3. Deprescribing Recommendations - Decide which meds to cut, in what order, and how fast. Prioritize the riskiest ones first.
4. Synthesis - Put it all together in a clear plan, share it with the patient, and schedule follow-ups.

A 2023 trial found this method reduced medications by 1.8 on average at discharge from a care facility-and still cut 1.6 meds at 90 days. That’s not a fluke. It’s repeatable.

Who Should Do It? Pharmacists Are Key

Doctors are stretched thin. A typical primary care visit lasts just over 7 minutes. That’s not enough time to review 12 medications, talk about goals, and answer fears.

That’s where pharmacists come in. Studies show deprescribing succeeds 35-40% more often when pharmacists lead it. They have the training, the time, and the tools. In Canada, where pharmacist-led deprescribing is routine, over 60% of clinics have formal protocols. In the U.S., it’s under 30%.

Pharmacists trained in medication therapy management (MTM) spend hours with patients. They map out drug interactions, check kidney and liver function, and explain why stopping a pill might be safer than keeping it. One pharmacist in Ontario reported successfully tapering 18 out of 22 elderly patients off benzodiazepines-with only two having mild withdrawal.

The Hidden Barriers: Time, Tools, and Fear

Even with solid evidence, deprescribing isn’t easy. Three big barriers stand in the way:

• Time - Most doctors don’t have 30 minutes to sit down with a patient and untangle a medication list. Electronic health records don’t help-they’re built for adding meds, not removing them.
• Tools - Only 32% of U.S. clinicians feel their EHR systems support deprescribing. No alerts. No prompts. No easy way to track taper schedules.
• Fear - Patients (and sometimes doctors) worry that stopping a drug will cause a relapse. A 2022 study found 22% of older adults felt anxious about discontinuing medications they’d taken for decades. Many think, “If it was prescribed, it must be necessary.”

The fix? Start small. Use free tools like deprescribing.org’s algorithms. Train nurses to flag high-risk meds during routine visits. Use the STOPP/START criteria to make decisions objective, not emotional.

What’s Changing in 2026?

Change is coming fast. In June 2024, the American Medical Association passed its first official policy: “Physicians should routinely assess the continuing appropriateness of all medications.” That’s huge.

Starting in 2026, Medicare will start measuring deprescribing in its payment system. Hospitals and clinics will be scored on how often they reduce inappropriate prescriptions. The goal? Cut medication-related hospitalizations by 40% by 2035.

New AI tools are also being tested. One system at a Boston hospital now flags patients on five or more meds and automatically suggests three drugs to review. It doesn’t decide-just nudges. Clinicians are still in charge. But now, they have a reminder.

What Patients Should Know

If you or a loved one is on five or more medications, ask these questions:

• Which of these drugs are still treating a real problem?
• Is this medication helping me feel better-or just adding side effects?
• Have we talked about what would happen if I stopped one of these?
• Can I try reducing the dose slowly to see how I feel?

Don’t stop anything on your own. But do start the conversation. Many people feel better after cutting just one or two unnecessary pills. Less nausea. Fewer falls. More sleep. More clarity.

What’s Missing? The 500+ Gaps

Here’s the hard truth: we have clear guidelines for five drug classes. But there are over 500 combinations of medications used in older adults with no evidence-based deprescribing advice. Anticoagulants. Antidepressants. Blood pressure drugs used with kidney disease. We’re still in the early days.

The National Institutes of Health is funding research to build guidelines for eight more classes by 2027. Until then, clinicians must rely on clinical judgment, patient goals, and careful monitoring.

Final Thought: It’s Not About Less Medicine. It’s About Better Medicine.

Deprescribing isn’t anti-medication. It’s pro-safety. It’s pro-clarity. It’s about matching treatment to the person-not the protocol.

A 78-year-old with dementia doesn’t need a statin to lower cholesterol if she’s not living to 90. A 72-year-old with mild arthritis doesn’t need three painkillers if one works fine. And a patient who’s been on a PPI for 10 years? Maybe they’ve forgotten why they started it in the first place.

The future of care isn’t more pills. It’s smarter pills. Fewer, but better chosen. And that starts with asking: Do I still need this?